In real-world settings, efficacy may differ due to patients ability to remember to take the medication, administer it properly, tolerate its side effects, and more
Novo's edge is the deeper clinical evidence behind semaglutide, particularly the cardiovascular data, and a three-month head start in prescriptions
This press release was written by Isabella Davis Contact: [email protected] DOI: 10.1038/s41419-026-09108-y JOURNAL Cell Death and Disease AUTHORS David Soriano-Castell, Marie Goujon, Nawab John Dar, Antonio Currais, Pamela Maher Office of Communications Tel: (858) 453-4100 [email protected] The Salk Institute is an independent, nonprofit research institute founded in 1960 by Jonas Salk, developer of the first safe and effective polio vaccine
Malnutrition (subjective global assessment) scores and serum albumin levels, but not body mass index values, at initiation of dialysis are independent predictors of mortality: a 10-year clinical cohort study